Navigation Links
MSU investigates drug to halt Parkinson's progression
Date:7/29/2011

GRAND RAPIDS, Mich. Researchers from Michigan State University's College of Human Medicine, Van Andel Research Institute and the Translational Genomics Research Institute are investigating a drug that has the potential to not only alleviate Parkinson's symptoms but also halt the disease's progression.

A $400,000 grant from the Michael J. Fox Foundation for Parkinson's Research part of $2.4 million in funding the foundation awarded this week to institutions nationwide will fund the research project.

Researchers are focusing on the drug Fasudil, which is currently approved in Japan to improve blood flow to the brain in stroke victims and has shown similar positive outcomes in U.S. clinical trials.

In 2009, investigators from the Translational Genomics Research Institute in Arizona and Arizona State University reported that a form of Fasudil had the potential to help improve learning and memory and reduce the risk of Alzheimer's disease. Van Andel researchers also recently discovered the potential of the drug in Parkinson's when they were testing various drugs that reduce the toxicity caused by a defective PARK1 gene, a gene implicated in Parkinson's disease.

"The potential of this drug is exciting not only because it could halt disease progression where other treatments only provide symptomatic relief but also because of how quickly it could be made available to patients," said Jeffrey P. MacKeigan, head of Van Andel's Laboratory of Systems Biology and co-investigator on the project with Caryl E. Sortwell of MSU's College of Human Medicine.

"Fasudil has a very favorable safety profile in humans and already is available in Japan as an oral tablet, so we could be seeing clinical trials within two to three years," MacKeigan added.

The development of new drugs is expensive and time-consuming, said Kuldip Dave, associate director of research programs at MJFF.

"In fall 2010, MJFF launched our inaugural repositioning program to address these realities and to attempt to reduce the time and costs involved in finding drugs that could help people living with Parkinson's," Dave said.

The next step in the project is for researchers from MSU to validate the therapeutic use of Fasudil in disease models of Parkinson's. Ultimately, the goal is to determine whether Fasudil has the therapeutic potential to protect and restore degenerating neurons in Parkinson's.

"This collaboration highlights the strength of strategically aligning teams from two research organizations with different skill sets," said MSU's Sortwell, a professor in the Division of Translational Science and Molecular Medicine. "The Van Andel/TGen team has expertise in cell biology and proteomics, while our researchers have extensive experience in Parkinson's disease systems biology and modeling. Together both organizations share the goal of helping those afflicted with Parkinson's to live better lives as a result of their respective research programs."


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert

Related medicine news :

1. Long Island Press Investigates Big Tobacco's Lobby to Kill Indian Cigarette Trade
2. Food Safety Law Firm Investigates Major Outbreak of E. coli Linked To Lettuce
3. Thesis investigates characteristics of society using sports activities as research tool
4. UI study investigates variability in mens recall of sexual cues
5. BUSM investigates cellular mechanisms leading to immune response in airway epithelium
6. New genomics research investigates metastatic childhood cancers
7. Herpes Drug Might Also Slow HIV Progression
8. Targeting the blood-brain barrier may delay progression of Alzheimers disease
9. Statins may slow progression of multiple sclerosis, new study finds
10. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
11. Exercise may slow progression of ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain ... inventor from Austin, Texas, has identified a solution. , She developed a prototype for ... lighting. As such, it eliminates the need to turn on a light when taking ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 West Pharmaceutical Services, ... solutions for injectable drug administration, today announced that it ... opens on Thursday, October 26, 2017, and will follow ... business expectations at 9:00 a.m. Eastern Time. To participate ... (International). The conference ID is 94093362. ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
Breaking Medicine Technology: